354 related articles for article (PubMed ID: 24337584)
1. Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway.
Lv Z; Wang C; Yuan T; Liu Y; Song T; Liu Y; Chen C; Yang M; Tang Z; Shi Q; Weng Y
Oncol Rep; 2014 Feb; 31(2):989-94. PubMed ID: 24337584
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein 9 facilitates osteocarcinoma cell apoptosis and inhibits in vivo tumor growth.
Zhang J; Liang JH; Huang JG
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706722
[TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic protein 9 overexpression reduces osteosarcoma cell migration and invasion.
Lv Z; Yang D; Li J; Hu M; Luo M; Zhan X; Song P; Liu C; Bai H; Li B; Yang Y; Chen Y; Shi Q; Weng Y
Mol Cells; 2013 Aug; 36(2):119-26. PubMed ID: 23807047
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor DLC-1 induces apoptosis and inhibits the growth and invasion of colon cancer cells through the Wnt/β-catenin signaling pathway.
Wang C; Wang J; Liu H; Fu Z
Oncol Rep; 2014 May; 31(5):2270-8. PubMed ID: 24604602
[TBL] [Abstract][Full Text] [Related]
5. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
Zhu B; Cheng D; Li S; Zhou S; Yang Q
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway.
Zhu XB; Zhang ZC; Han GS; Han JZ; Qiu DP
Mol Med Rep; 2017 Apr; 15(4):1884-1892. PubMed ID: 28260089
[TBL] [Abstract][Full Text] [Related]
7. The tumor suppressive role of RASSF1A in osteosarcoma through the Wnt signaling pathway.
Wang WG; Chen SJ; He JS; Li JS; Zang XF
Tumour Biol; 2016 Jul; 37(7):8869-77. PubMed ID: 26750098
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway.
Ma Y; Zhu B; Liu X; Yu H; Yong L; Liu X; Shao J; Liu Z
J Exp Clin Cancer Res; 2015 Oct; 34():115. PubMed ID: 26444270
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-329-3p inhibits the Wnt/β-catenin pathway and proliferation of osteosarcoma cells by targeting transcription factor 7-like 1.
Sun H; Kawano M; Iwasaki T; Itonaga I; Kubota Y; Tsumura H; Tanaka K
Oncol Res; 2024; 32(3):463-476. PubMed ID: 38370338
[TBL] [Abstract][Full Text] [Related]
10. CD151 knockdown inhibits osteosarcoma metastasis through the GSK-3β/β-catenin/MMP9 pathway.
Zhang Z; Wang F; Li Q; Zhang H; Cui Y; Ma C; Zhu J; Gu X; Sun Z
Oncol Rep; 2016 Mar; 35(3):1764-70. PubMed ID: 26707073
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory Effect of MicroRNA-107 on Osteosarcoma Malignancy Through Regulation of Wnt/β-catenin Signaling in Vitro.
Yu M; Guo D; Cao Z; Xiao L; Wang G
Cancer Invest; 2018 Mar; 36(3):175-184. PubMed ID: 29565702
[TBL] [Abstract][Full Text] [Related]
12. Overexpressing circular RNA hsa_circ_0002052 impairs osteosarcoma progression via inhibiting Wnt/β-catenin pathway by regulating miR-1205/APC2 axis.
Wu Z; Shi W; Jiang C
Biochem Biophys Res Commun; 2018 Aug; 502(4):465-471. PubMed ID: 29852168
[TBL] [Abstract][Full Text] [Related]
13. Polyphyllin I suppresses human osteosarcoma growth by inactivation of Wnt/β-catenin pathway in vitro and in vivo.
Chang J; Li Y; Wang X; Hu S; Wang H; Shi Q; Wang Y; Yang Y
Sci Rep; 2017 Aug; 7(1):7605. PubMed ID: 28790389
[TBL] [Abstract][Full Text] [Related]
14. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
Chen Q; Zheng PS; Yang WT
Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-152 inhibits cell proliferation of osteosarcoma by directly targeting Wnt/β-catenin signaling pathway in a DKK1-dependent manner.
Zhao X; Sun S; Xu J; Luo Y; Xin Y; Wang Y
Oncol Rep; 2018 Aug; 40(2):767-774. PubMed ID: 29845282
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.
Shimozaki S; Yamamoto N; Domoto T; Nishida H; Hayashi K; Kimura H; Takeuchi A; Miwa S; Igarashi K; Kato T; Aoki Y; Higuchi T; Hirose M; Hoffman RM; Minamoto T; Tsuchiya H
Oncotarget; 2016 Nov; 7(47):77038-77051. PubMed ID: 27780915
[TBL] [Abstract][Full Text] [Related]
17. SiRNA-mediated silencing of beta-catenin suppresses invasion and chemosensitivity to doxorubicin in MG-63 osteosarcoma cells.
Zhang F; Chen A; Chen J; Yu T; Guo F
Asian Pac J Cancer Prev; 2011; 12(1):239-45. PubMed ID: 21517265
[TBL] [Abstract][Full Text] [Related]
18. Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt/β-catenin signaling.
Liu Y; Wang W; Xu J; Li L; Dong Q; Shi Q; Zuo G; Zhou L; Weng Y; Tang M; He T; Luo J
Oncol Rep; 2013 Oct; 30(4):1723-30. PubMed ID: 23917613
[TBL] [Abstract][Full Text] [Related]
19. The overexpression of BAMBI and its involvement in the growth and invasion of human osteosarcoma cells.
Zhou L; Park J; Jang KY; Park HS; Wagle S; Yang KH; Lee KB; Park BH; Kim JR
Oncol Rep; 2013 Sep; 30(3):1315-22. PubMed ID: 23807684
[TBL] [Abstract][Full Text] [Related]
20. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
Jiang Z; Jiang C; Fang J
Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]